microdosing tirzepatide protocol I'm starting a new longevity protocol: Tirzepatide, a dual GLP-1/GIP receptor agonist. Here is the existing evidence, my protocol, measurement plan, and what I expect to achieve by this intervention. 🧵 Microdosing tirzepatide chart: Guide to

It minimises material investment in the early stages of a research project

Results typically emerge within 24 weeks, with maximum benefit observed at 1620 weeks of consistent use

Since glutathione is a key antioxidant responsible for cellular repair, detoxification, and immune defense, IV therapy ensures the body receives it in the most effective way

Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response 6

External support services Access-A-Ride web.mta.info/nyct/paratran/guide.htm 877-337-2017 In New York City, the MTA offers a shared ride, door-to-door service for people with disabilities who cant take the public bus or subway